Last reviewed · How we verify

NCT05307224

The Effect of Mandala Painting on Anxiety in Coronary Heart Patients

Completed NA Last updated 25 September 2023
What this trial tests

NA trial testing Mandala in Coronary Artery Disease in 60 participants. Completed in 23 September 2023.

Timeline
9 August 2023
Primary endpoint
9 August 2023
23 September 2023

Quick facts

Lead sponsorMarmara University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment60
Start date9 August 2023
Primary completion9 August 2023
Estimated completion23 September 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Marmara University

Who can join

Adults 18 to 85, any sex, with Coronary Artery Disease or Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was planned as a randomized controlled trial to determine the effect of mandala painting on the anxiety of coronary heart patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Mandala

Trials testing the same drug.

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

Other Marmara University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05307224.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing